Literature DB >> 3723362

Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

R Heintz, C K Svensson, K Stoeckel, G J Powers, D Lalka.   

Abstract

The plasma concentration-time profile of indocyanine green (1) in the rabbit was determined by spectrophotometric and high-performance liquid chromatographic (HPLC) analysis following doses of 5 or 25 mg/kg. Spectrophotometric analysis yielded plasma concentration estimates that were higher than those obtained by an HPLC method and this difference was particularly large at time points greater than or equal to 30 min postdose. Chromatograms of plasma samples from each rabbit exhibited two peaks, both of which were maximal in the first postdose sample, suggesting an impurity in the commercial preparation. HPLC analysis of five different lots of 1 suggested a variable abundance of this impurity (1.7-4.0%). When stored in a variety of aqueous solutions, 1 degraded to a compound with a retention time identical to that of the impurity. The time for 50% degradation of 1 in deionized, distilled, and sterile water was 19, 92, and 99 h, respectively, and the rate of decay in these solvents exhibited significant interday variability. Dilute acetic acid (approximately 20 mM; pH = 3.2) was found to substantially accelerate this degradation (50% degradation in less than 1 h). Interestingly, this acid-catalyzed rate of conversion of 1 to the degradation product fit about equally well assuming a zero-order or first-order process. In an effort to elucidate the structure of this degradation product (impurity), UV-visible spectra of appropriate column eluates were obtained. The spectra of these compounds differed from that of 1 in only minor details.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723362     DOI: 10.1002/jps.2600750417

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.

Authors:  G A Brazeau; H L Fung
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Liver Function, Quantified by LiMAx Test, After Major Abdominal Surgery. Comparison Between Open and Laparoscopic Approach.

Authors:  Magnus Kaffarnik; Gabriel Stoeger; Julia Liebich; Christian Grieser; Johann Pratschke; Martin Stockmann
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice.

Authors:  S G Kulkarni; A A Pegram; P C Smith
Journal:  AAPS PharmSci       Date:  2000

4.  Pharmacokinetics of biliary excretion in man. VI. Indocyanine green.

Authors:  D K Meijer; B Weert; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Authors:  P A Soons; A De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

6.  Experimental impact of assay-dependent differences in plasma indocyanine green concentration determinations.

Authors:  D M Grasela; M L Rocci; P H Vlasses
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

7.  Pharmacokinetics of the enantiomers of ibuprofen in the rabbit.

Authors:  K M Williams; R D Knihinicki; R O Day
Journal:  Agents Actions       Date:  1991-11

8.  Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test.

Authors:  Magnus F Kaffarnik; Johan F Lock; Hannah Vetter; Navid Ahmadi; Christian Lojewski; Maciej Malinowski; Peter Neuhaus; Martin Stockmann
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.